Teprotumumab-trbw (Tepezza; Amgen) has demonstrated clinical benefit in thyroid eye disease (TED), but less is known about ...

In the latest episode of The Retina TL;DR with Dr. Weng—Part 2 of a special two-part series—host Christina Y. Weng, MD, MBA, ...

October 16, 2026, delivered 3 ophthalmic FDA approvals that, taken together, touch nearly every corner of the eye care ...

IRIS Registry data showed no change in anti-VEGF frequency, vision, or retinal thickness after patients with DME began a GLP-1RA. The study was prompted by an observation from Nagalamadaka's principal ...

Docking the trailing haptic is the step where surgeons most often struggle with the Yamane technique, according to Murtaza K.

Omur Ucakhan, MD, explains why artificial tears are not interchangeable and how dry eye phenotype should guide formulation ...

The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during ...

Eleonora Lad, MD, PhD, Dimitra Skondra, MD, PhD, and John Kitchens, MD, point to structure and function, diet and the gut, ...

A study published in JAMA Ophthalmology 1 reported that spectacle lenses with highly aspherical lenslets (HAL) are safe and ...

The milestone moves what Oculis describes as the first genotype-guided registrational trial in DED a step closer to a readout ...

Patients who say their eyes feel dry, gritty, or burning are among the most common in ophthalmology, and treating them well ...

The 2 complement inhibitors approved by the US Food and Drug Administration (FDA) for geographic atrophy (GA) secondary to ...